Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
Clinical trial NCT05266716 · COMPLETED
Trial details
- NCT number
- NCT05266716
- Sponsor
- Affect Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2021-06-30
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.